col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


191 Ergebisse       Seite 1

 [1] 
American Chemical Society: ACS Omega
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Dez―17 Chromene-Thiazole Derivatives as Potential SARS-CoV-2 M pro Inhibitors: Synthesis and Computational Studies Lauren D. Stettler, Vincent T. Kopysciansky, Jenna E. Poor, Gabriela de Lima Menezes, Elton VanNoy, Guilherme Bastos Alves, et al. (+7)
2 [GO] 2025―Dez―11 Rapid Detection of SARS-CoV-2 Spike Protein Using a Fully 3D-Printed Electrochemical Biosensor Dayenny L. D’Amato, Natália M. Caldas, Lucas V. de Faria, Ana Beatriz C. Souza, Guilherme P. Oliveira, Diego O. Costa, et al. (+3)
3 [GO] 2025―Dez―05 Dynamical Fragment Molecular Orbital Interaction Analysis of SARS-CoV-2 RNA-Dependent RNA Polymerase and Remdesivir Shuhei Miyakawa, Koji Okuwaki, Yusuke Kawashima, Yuma Handa, Takayuki Furuishi, Etsuo Yonemochi, et al. (+2)
4 [GO] 2025―Nov―15 A Tetrapodal Tryptophan Derivative with Multiple Exposed Free Carboxylic Acids Blocks Host Cell Entry of Omicron SARS-Cov-2 and Respiratory Syncytial Virus Olaia Martí-Marí, Marta Moreno-Simoni, Ana Isabel Avilés-Alía, Luciana Rusu, Alicia Forcada-Nadal, Anmol Adhav, et al. (+12)
5 [GO] 2025―Nov―12 Gas-Phase Electrophoresis (nES GEMMA Instrumentation) of SARS-CoV-2-Based Virus-like Particles Victor U. Weiss, Martina Marchetti-Deschmann
6 [GO] 2025―Okt―24 Noncompetitive Fluorescence Polarization Aptamer Assay for Detecting SARS-CoV-2 Variants Chang Yu-Ting, Rigel Suzuki, Yoichiro Fujioka, Akihiko Ishida, Ayuko Imai, Mao Fukuyama, et al. (+7)
7 [GO] 2025―Okt―02 SARS-CoV-2 Papain-Like Protease Inhibitors Based on Naphthalen-1-ylethanamine and Halogenated Benzene Moieties Kouki Shinohara, Takuya Kobayakawa, Kohei Tsuji, Yuki Takamatsu, Hiroaki Mitsuya, Hirokazu Tamamura
8 [GO] 2025―Okt―01 Visible-Light-Driven Photoactivity of Copper/PVA Composite Films against Murine Coronavirus Aline L. Schio, Michele S. de Lima, Marina D. Giustina, Rafael D. Cadamuro, Catielen P. Pavi, Alexandre F. Michels, et al. (+3)
9 [GO] 2025―Sep―25 Rapid, On-Site SARS-CoV-2 Variant Detection and Differentiation Using GLAD-Pristine Silver Nanorod Arrays and Machine Learning-Enhanced SERS Sneha Senapati, Arvind Kaushik, Aditya Singh, Ishaan Gupta, Rashmi Virkar, Smita S. Kulkarni, et al. (+2)
10 [GO] 2025―Sep―25 How the Universal MSA52 Aptamer Recognizes the SARS-CoV-2 Spike Protein Tadsanee Awang, Firdaus Samsudin, Deanpen Japrung, Peter John Bond, Prapasiri Pongprayoon
11 [GO] 2025―Sep―25 Facile Synthesis of Lecithin-Sophorolipid Liponiosomes Encapsulating SARS-CoV-2 Proteins for Therapeutic Applications Sristy Shikha, Soni Kumari, Ankita Jain, Navjot Kaur, Mukesh Kumar Jogi, Mani Shankar Bhattacharyya, et al. (+4)
12 [GO] 2025―Sep―11 Screening of Medicines for Malaria Venture Open Boxes Identifies Potent SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Victor Oliveira Gawriljuk, Gabriela Dias Noske, Rafaela Sachetto Fernandes, Aline Minalli Nakamura, Marjorie C. L. C. Freire, Mariana Ortiz Godoy, et al. (+17)
13 [GO] 2025―Sep―08 MALDI-TOF MS and Machine Learning Explanations for the Detection of SARS-CoV-2 Infection in Human Plasma: Fingerprints as a Strategy for Risk Assessment Meritxell Deulofeu, Esteban García-Cuesta, Eladia María Peña-Méndez, José Elías Conde-González, Orlando Jiménez-Romero, Enrique Verdú, et al. (+3)
14 [GO] 2025―Aug―27 SARS-CoV-2 Main Protease Inhibitors Containing 5-Substituted Benzothiazole-2-carbonyl Moieties at the P1′ Site and Their Derivatives Kohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Takahiro Ishii, Kouki Shinohara, Ryusei Yamamoto, et al. (+4)
15 [GO] 2025―Aug―25 Exploring SARS-CoV-2 Spike RBD Pockets as Targets for Generic Drugs: A Combined Computational, Biophysical, and Biological Approach Javier García-Marín, Clara Francés-Gómez, Alicia Forcada-Nadal, Anmol Adhav, Clara Marco-Marín, Vicente Rubio, et al. (+4)
16 [GO] 2025―Aug―05 Molecular Insights into the Interaction between CD147 and the SARS-CoV-2 Spike Protein Milton S. Gonzalez-Serrano, Li-Yu Chen, Hemi Desai, Thi Huynh Ho, Doris Heinrich, Thuat Thanh Trinh, Thi-Huong Nguyen
17 [GO] 2025―Aug―05 An In Silico Investigation of Brazilian Green Propolis Extracts as Potential Treatment for COVID-19 Jeronimo Geraldo Ferreira Júnior, Janaína Brandão Seibert, Viviane Martins Rebello dos Santos, Lucas Resende Dutra Sousa, Tatiane Roquete Amparo, Thalita Marcolan Valverde, et al. (+5)
18 [GO] 2025―Jul―31 ACE2 Receptor and Antibody Binding to SARS-CoV-2 Spikes and Virions by Single-Molecule Fluorescence Souradip Dasgupta, Srijan Ray, Aswin T. Srivatsav, Anthony L. DeVico, Krishanu Ray
19 [GO] 2025―Jul―31 Human Helicase DDX5 is Hijacked by SARS-CoV-2 Nsp13 Helicase to Enhance RNA Unwinding Giovanni Barra, Alessia Ruggiero, Valeria Napolitano, Camilla Lodola, Massimiliano Secchi, Maria Michela Pallotta, et al. (+4)
20 [GO] 2025―Jul―01 SARS-CoV-2 RNA’s Dual Identity: G-Quadruplex versus Hairpin Alex Nyporko, Ivan Voiteshenko, Margarita Zarudnaya, Vasyl Hurmach, Tetiana Shyryna, Maksym Platonov, et al. (+3)
21 [GO] 2025―Jun―11 Cerebrospinal Fluid Proteomic Profiling Reveals Proteins Associated with Neuroinflammatory Response in COVID-19 Patients Juliana Ramos de Andrade, Josivan Barbosa de Farias, Maria Luiza de Lima Vitorino, Fernando Tenório Travassos, Roberto Afonso da Silva, José Luiz de Lima Filho, Marcelo Moraes Valença
22 [GO] 2025―Jun―04 In Silico Discovery of a Novel Antiviral Scaffold for SARS-CoV-2 Targeting the Spike Glycoprotein through the Fatty Acid Binding Pocket Luís Queirós-Reis, Mari Kaarbo̷, Huda Al-Baldawi, Rui Alvites, Ana Colette Maurício, Andrea Brancale, et al. (+2)
23 [GO] 2025―Jun―03 Development of Novel ssDNA Aptamers for Detection of Receptor-Binding Domain of SARS-COV-2 Amogh Auti, Pranay Yadav, Rahul Bodkhe, Yogesh Bhandari, Sanjana Varma, Bhushan Chaudhari, et al. (+3)
24 [GO] 2025―Mai―23 Modified Bis-pyrimidine Clamps for Triplex Formation and Their Use in SARS-CoV-2 Detection Arnau Domínguez, Raimundo Gargallo, Carlos Cuestas-Ayllón, Irene Gomez-Pinto, Carme Fàbrega, Jesús Martínez de la Fuente, et al. (+4)
25 [GO] 2025―Apr―21 Replication Features of SARS-CoV-2 and Advantages of Targeting S Protein with Aptamers to Block Viral Entry Jun Zheng, Qiuxia Pang, Zhaoying Fu
26 [GO] 2025―Mrz―31 Retraction of “Promising Experimental Anti-SARS-CoV-2 Agent “SLL-0197800”: The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus” Amgad M. Rabie, Marwa A. Abdel-Dayem, Mohnad Abdalla
27 [GO] 2025―Jan―21 Antiviral Activity of Electrospun Polyamide Ultrathin Fibers Against SARS-CoV-2 Variant Moisés V. Santana, Gustavo F. Sousa, Millena C. S. Silva, Lays Cordeiro Guimaraes, Leonardo Camilo de Oliveira, Pedro H. D. M. Prazeres, et al. (+15)
28 [GO] 2025―Jan―10 Identifying Natural Products as Feline Coronavirus Mpro Inhibitors by Structural-Based Virtual Screening and Enzyme-Based Assays Zunyun Jiang, Lianhua Piao, Changyi Ren, Weihua Zhang, Yingguang Zhu, Ren Kong
29 [GO] 2024―Dez―20 Green Synthesis of Tetrahydropyrazino[2,1-a:5,4-a′]diisoquinolines as SARS-CoV-2 Entry Inhibitors Sowndarya Palla, Srinivasa Rao Palla, Jia-Jin Liu, Tai-Ling Chao, Ting-Hui Lee, Veerababurao Kavala, et al. (+5)
30 [GO] 2024―Nov―06 Multiplatform Metabolomics: Enhancing the Severity Risk Prognosis of SARS-CoV-2 Infection Vinicius S. Lima, Sinara T. B. Morais, Vinicius G. Ferreira, Mariana B. Almeida, Manuel Pedro Barros Silva, Thais de A. Lopes, et al. (+8)
31 [GO] 2024―Okt―24 Inhibitory Effects of Mangifera indica Secondary Metabolites and Their Synthetic Derivatives against SARS-CoV-2 Mpro and NS2B/NS3 (ZIKV and DENV-2) Gabriella B. Souza, Carime L. M. Pontes, Geovanna de O. Costa, Natália F. de Sousa, Tiago Tizziani, Luiz Antonio E. Pollo, et al. (+7)
32 [GO] 2024―Okt―10 Multiomics Reveals a Mechanism: Glycogen Synthesis, Galactose Metabolism, and Ethanol Degradation Pathways, the Durable Role of Neutralizing Antibodies in Preventing COVID-19 Huayu Luo, Linrui Fan, Feng Cao, Tong Ren, Yujie He, Tao Shen, et al. (+2)
33 [GO] 2024―Okt―01 Use of NIR in COVID-19 Screening: Proof of Principles for Future Application Matthews S. Martins, Marcia H. C. Nascimento, Leonardo B. Leal, Wilson J. Cardoso, Vandack Nobre, Cecilia G. Ravetti, et al. (+3)
34 [GO] 2024―Sep―25 Binding Mechanism of the Active Form of Molnupiravir to RdRp of SARS-CoV-2 and Designing Potential Analogues: Insights from Molecular Dynamics Simulations Justin Carbone, Nicholas J. Paradis, Dylan Brunt, Chun Wu
35 [GO] 2024―Sep―25 Inhibition of the SARS-CoV-2 Non-structural Protein 5 (NSP5) Protease by Nitrosocarbonyl-Bases Small Molecules Marco Leusciatti, Beatrice Macchi, Francesca Marino-Merlo, Valeria Stefanizzi, Antonio Mastino, Giulia Morra, Paolo Quadrelli
36 [GO] 2024―Sep―20 Optimization of Reverse Transcription Loop-Mediated Isothermal Amplification for In Situ Detection of SARS-CoV-2 in a Micro-Air-Filtration Device Format Jacob Fry, Jean Y. H. Lee, Julie L. McAuley, Jessica L. Porter, Ian R. Monk, Samuel T. Martin, et al. (+4)
37 [GO] 2024―Aug―20 Repurposed Drugs during the Outbreak of Pandemic COVID-19: A Mini-Review on Their Molecular Structures and Hit-and-Trial Results Thangjam Linda Devi, Mayanglambam Maneeta Devi, Monika Okram, Okram Mukherjee Singh
38 [GO] 2024―Aug―16 Characterization of the SARS-CoV-2 Genome 3′-Untranslated Region Interactions with Host MicroRNAs Caleb J. Frye, Caylee L. Cunningham, Mihaela Rita Mihailescu
39 [GO] 2024―Aug―16 Correction to “Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2” Abdul-Rahman Azizogli, Varun Pai, Francesco Coppola, Roya Jafari, Joseph B. Dodd-o, Rohan Harish, et al. (+5)
40 [GO] 2024―Aug―02 Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro) Yue Yang, Yi-Dan Luo, Chen-Bo Zhang, Yang Xiang, Xin-Yue Bai, Die Zhang, et al. (+3)
41 [GO] 2024―Jul―30 Enhancing Immune Responses against SARS-CoV-2 Variants in Aged Mice with INDUK: A Chimeric DNA Vaccine Encoding the Spike S1-TM Subunits Lishan Cui, Junbiao Wang, Fiorenza Orlando, Robertina Giacconi, Marco Malavolta, Beatrice Bartozzi, et al. (+12)
42 [GO] 2024―Jul―17 Rational Design Problematics of Peptide Nucleic Acids as SARS-CoV-2 Inhibitors Tatyana A. Grigoreva, Svetlana V. Vorona, Daria S. Novikova, Vyacheslav G. Tribulovich
43 [GO] 2024―Jun―24 Microfluidic Immunoarray for Point-of-Care Detection of Cytokines in COVID-19 Patients Ketki S. Bhalerao, P. I. Thilini De Silva, Keshani Hiniduma, Ami Grunbaum, Nicholas Rozza, Richard Kremer, James F. Rusling
44 [GO] 2024―Jun―07 SARS-CoV-2 Protein Nsp9 Is Involved in Viral Evasion through Interactions with Innate Immune Pathways Eryn Lundrigan, Caroline Toudic, Emily Pennock, John Paul Pezacki
45 [GO] 2024―Jun―04 New Pyrimidinone Bearing Aminomethylenes and Schiff Bases as Potent Antioxidant, Antibacterial, SARS-CoV-2, and COVID-19 Main Protease MPro Inhibitors: Design, Synthesis, Bioactivities, and Computational Studies Muhammad Sarfraz, Muhammad Ayyaz, Abdul Rauf, Asma Yaqoob, Muhammad Arif Ali, Sabir Ali Siddique, et al. (+5)
46 [GO] 2024―Apr―11 Rapid and Accurate Detection of the SARS-CoV-2 Omicron Variant with a CRISPR-Cas12a Reaction in the RT-qPCR Pot Raúl Ruiz, Roser Montagud-Martínez, Alexis Dorta-Gorrín, Daniel Pablo-Marcos, Mónica Gozalo, Jorge Calvo-Montes, et al. (+2)
47 [GO] 2024―Apr―02 Animal Cell Lines as Expression Platforms in Viral Vaccine Production: A Post Covid-19 Perspective S. Furkan Demirden, Ilgin Kimiz-Gebologlu, Suphi S. Oncel
48 [GO] 2024―Mrz―27 Theoretical Investigation of the Green-Synthesized Carbon-Based Nanomaterial Potential as Inhibitors of ACE2 for Blocking SARS-CoV-2 Binding Harsiwi Candra Sari, Haliza Hasnia Putri, Pinantun Wiguna Kusuma Paksi, Gabriel Hidayat, Silmi Rahma Amelia, Citra Deliana Dewi Sundari, et al. (+4)
49 [GO] 2024―Mrz―22 Uncovering the Effect of SARS-CoV-2 on Liver Metabolism via Genome-Scale Metabolic Modeling for Reprogramming and Therapeutic Strategies Mustafa Sertbas, Kutlu O. Ulgen
50 [GO] 2024―Feb―28 Unveiling the Antiviral Capabilities of Targeting Human Dihydroorotate Dehydrogenase against SARS-CoV-2 Aline D. Purificação, Sabrina Silva-Mendonça, Luiza V. Cruz, Carolina Q. Sacramento, Jairo R. Temerozo, Natalia Fintelman-Rodrigues, et al. (+15)
51 [GO] 2024―Feb―15 Coupling of SARS-CoV-2 to Aβ Amyloid Fibrils Francesco Coppola, Tomáš Pavlíček, Petr Král
52 [GO] 2024―Feb―14 Biophysical Analysis of Potential Inhibitors of SARS-CoV-2 Cell Recognition and Their Effect on Viral Dynamics in Different Cell Types: A Computational Prediction from In Vitro Experimental Data Lenin González-Paz, Carla Lossada, María Laura Hurtado-León, Joan Vera-Villalobos, José L. Paz, Yovani Marrero-Ponce, et al. (+2)
53 [GO] 2024―Jan―26 The Application of Biomaterials for the Vaccine, Treatment, and Detection of SARS-CoV-2 Yuan Hu, Lili Liu, Shenghua Zhang, Shaoyu Su, Xiao Liang
54 [GO] 2024―Jan―19 Correction to “Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection” Soledad Stagnoli, Gabriele Macari, Pietro Corsi, Barbara Capone, Ander Vidaurrazaga, June Ereño-Orbea, et al. (+5)
55 [GO] 2024―Jan―18 Allosteric Signal within the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein Mediated by a Class 3 Monoclonal Antibody Revealed through Molecular Dynamics Simulations and Protein Residue Networks Patamalai Boonserm, Wasusit Somsoros, Pongsak Khunrae, Krit Charupanit, Praopim Limsakul, Thana Sutthibutpong
56 [GO] 2023―Dez―12 Exploring the Potential Association between COVID-19 and Thyroid Cancer: A Mendelian Randomization Study Dingtao Xu, Xinyu Wang, Dehua Zhou
57 [GO] 2023―Nov―22 Polyaniline/Titania Nanotube-Based Biosensor Strip for Sensitive and Specific Electrochemical Detection of SARS-CoV-2 Al-mahmnur Alam, Timsy Uppal, Md Shariful Islam, Manoranjan Misra, Subhash C Verma
58 [GO] 2023―Nov―21 Modulating SARS-CoV-2 Spike Protein Reactivity through Moderate Electric Fields: A Pathway to Innovative Therapies Thi-Huong Nguyen, Hanqing Wang, Li-Yu Chen, Danny Echtermeyer, Uwe Pliquett
59 [GO] 2023―Nov―17 COVID-19 ORF3a Viroporin-Influenced Common and Unique Cellular Signaling Cascades in Lung, Heart, and the Brain Choroid Plexus Organoids with Additional Enriched MicroRNA Network Analyses for Lung and the Brain Tissues Soura Chakraborty, Shrabonti Chatterjee, Subhashree Mardi, Joydeep Mahata, Suneel Kateriya, Pradeep Punnakkal, Gireesh Anirudhan
60 [GO] 2023―Nov―15 Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2 Elena Marchesi, Valentina Gentili, Daria Bortolotti, Lorenzo Preti, Paolo Marchetti, Virginia Cristofori, et al. (+5)
61 [GO] 2023―Nov―14 Antiviral Effects of Pyrroloquinoline Quinone through Redox Catalysis To Prevent Coronavirus Infection Nur Syafiqah Mohamad Ishak, Tomoe Numaguchi, Kazuto Ikemoto
62 [GO] 2023―Nov―13 Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection Soledad Stagnoli, Gabriele Macari, Pietro Corsi, Barbara Capone, Ander Vidaurrazaga, June Ereño-Orbea, et al. (+5)
63 [GO] 2023―Nov―01 Effect of Low Copper Doping on the Optical, Cytocompatible, Antibacterial, and SARS-CoV-2 Trapping Properties of Calcium Phosphate Glasses Elisa Restivo, Diego Pugliese, Duccio Gallichi-Nottiani, José Camilla Sammartino, Nora Bloise, Emanuela Peluso, et al. (+4)
64 [GO] 2023―Okt―30 Effect of COVID-19 mRNA Vaccine on Human Lung Carcinoma Cells In Vitro by Means of Raman Spectroscopy and Imaging Halina Abramczyk, Jakub Surmacki
65 [GO] 2023―Okt―19 Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral Activity Thane Jones, Natalia Monakhova, Florence Guivel-Benhassine, Alexander Lepioshkin, Timothée Bruel, Thomas R. Lane, et al. (+4)
66 [GO] 2023―Okt―03 Delineating the Structure-Dynamics-Binding Differences among BA.1, BA.4/5, and BF.7 SARS-CoV-2 Variants through Atomistic Simulations: Correlation with Structural and Epidemiological Features Aryaman Joshi, Shweata Maurya, Atharva Mahale, Soumya Lipsa Rath, Timir Tripathi, Aditya K. Padhi
67 [GO] 2023―Okt―02 High-Titer Recombinant Adenovirus 26 Vector GMP Manufacturing in HEK 293 Cells with a Stirred Single-Use Bioreactor for COVID-19 Vaccination Purposes Hossein Sedighikamal, Alireza Sattarzadeh, Reza Karimi Mostofi, Behnoush Dinarvand, Madineh Nazarpour
68 [GO] 2023―Sep―25 Synthesis and Biological Evaluation of Benzothiazolyl-pyridine Hybrids as New Antiviral Agents against H5N1 Bird Flu and SARS-COV-2 Viruses Nadia Hanafy Metwally, Galal Hamza Elgemeie, Fatma Gomaa Fahmy
69 [GO] 2023―Sep―20 Inhibition of the RNA-Dependent RNA-Polymerase from SARS-CoV-2 by 6-Chloropurine Isoxazoline-Carbocyclic Monophosphate Nucleotides Marco Leusciatti, Beatrice Macchi, Francesca Marino-Merlo, Antonio Mastino, Giulia Morra, Paolo Quadrelli
70 [GO] 2023―Sep―18 Promising Experimental Anti-SARS-CoV-2 Agent “SLL-0197800”: The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus Amgad M. Rabie, Marwa A. Abdel-Dayem, Mohnad Abdalla
71 [GO] 2023―Aug―31 Development of Rapid Aptamer-Based Screening Assay for the Detection of Covid-19 Variants Yumna M. Aloraij, Ghadeer A. R. Y. Suaifan, Atef Shibl, Khaled Al-Kattan, Mohammed M. Zourob
72 [GO] 2023―Aug―28 Cholesterol and Ceramide Facilitate Membrane Fusion Mediated by the Fusion Peptide of the SARS-CoV-2 Spike Protein Kristina Niort, Julia Dancourt, Erwan Boedec, Zahra Al Amir Dache, Grégory Lavieu, David Tareste
73 [GO] 2023―Aug―24 Cationic Chitosan Derivatives for the Inactivation of HIV-1 and SARS-CoV-2 Enveloped Viruses Zamani E. D. Cele, William Matshe, Lindani Mdlalose, Katlego Setshedi, Kanyane Malatji, Nompumelelo Prudence Mkhwanazi, et al. (+2)
74 [GO] 2023―Jul―25 Neurological Sequelae of COVID-19: A Biochemical Perspective Xiaoxiao Zhang, Ying Zhang, Ling Wen, Jess Lan Ouyang, Weiwei Zhang, Jiaming Zhang, et al. (+2)
75 [GO] 2023―Jul―24 Discovering Traditional Chinese Medicine (TCM) Formulas for Complex Diseases Based on a Combination of Reverse Systematic Pharmacology and TCM Meridian Tropism Theory: Taking COVID-19 as an Example Hongbo Chen, Xiaohong Zhang, Jiaying Li, Zhe Xu, Yiwei Luo, Rundong Chai, et al. (+3)
76 [GO] 2023―Jul―21 Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors Milan Štefek, Dominika Chalupská, Karel Chalupský, Michala Zgarbová, Alexandra Dvořáková, Petra Krafčíková, et al. (+11)
77 [GO] 2023―Jul―07 In Vitro Reconstitution and Analysis of SARS-CoV-2/Host Protein-Protein Interactions Shayli Varasteh Moradi, Yue Wu, Patricia Walden, Zhenling Cui, Wayne A. Johnston, Dmitri Petrov, Kirill Alexandrov
78 [GO] 2023―Jun―23 Evolution of Sequence and Structure of SARS-CoV-2 Spike Protein: A Dynamic Perspective Anushree Sinha, Satyam Sangeet, Susmita Roy
79 [GO] 2023―Jun―14 Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 Ana C. Puhl, Andre S. Godoy, Gabriela D. Noske, Aline M. Nakamura, Victor O. Gawriljuk, Rafaela S. Fernandes, et al. (+2)
80 [GO] 2023―Jun―13 Antiviral Activity against SARS-CoV-2 of Conformationally Constrained Helical Peptides Derived from Angiotensin-Converting Enzyme 2 Michael Quagliata, Maria Alfreda Stincarelli, Anna Maria Papini, Simone Giannecchini, Paolo Rovero
81 [GO] 2023―Jun―07 A Computational Pipeline to Identify and Characterize Binding Sites and Interacting Chemotypes in SARS-CoV-2 Sarah H. Sandholtz, Jeffrey A. Drocco, Adam T. Zemla, Marisa W. Torres, Mary S. Silva, Jonathan E. Allen
82 [GO] 2023―Apr―04 Interactome-Based Machine Learning Predicts Potential Therapeutics for COVID-19 Nimisha Ghosh, Indrajit Saha, Anna Gambin
83 [GO] 2023―Mrz―31 Pan-Cancer Analysis of the COVID-19 Causal Gene SLC6A20 Ahmet Acar
84 [GO] 2023―Mrz―23 Human Amylin in the Presence of SARS-COV-2 Protein Fragments Andrew D. Chesney, Buddhadev Maiti, Ulrich H.E. Hansmann
85 [GO] 2023―Feb―06 Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2 Abdul-Rahman Azizogli, Varun Pai, Francesco Coppola, Roya Jafari, Joseph B. Dodd-o, Rohan Harish, et al. (+5)
86 [GO] 2023―Feb―06 Exploration of SARS-CoV-2 Mpro Noncovalent Natural Inhibitors Using Structure-Based Approaches Cuong Quoc Duong, Phuong Thuy Viet Nguyen
87 [GO] 2023―Jan―30 Novel Investigational Anti-SARS-CoV-2 Agent Ensitrelvir “S-217622”: A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus Species Wafa A. Eltayb, Mohnad Abdalla, Amgad M. Rabie
88 [GO] 2023―Jan―10 Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots Paul F. Gillespie, Yanjie Wang, Carl Hofmann, Laura E. Kuczynski, Michael A. Winters, Jennifer L. Teyral, et al. (+4)
89 [GO] 2023―Jan―06 6-Shogaol Exhibits Anti-viral and Anti-inflammatory Activity in COVID-19-Associated Inflammation by Regulating NLRP3 Inflammasomes Jyoti Kode, Jitendra Maharana, Asif Amin Dar, Shayanti Mukherjee, Nikhil Gadewal, Dilep Kumar Sigalapalli, et al. (+10)
90 [GO] 2022―Dez―13 In Vitro Screening and MD Simulations of Thiourea Derivatives against SARS-CoV-2 in Association with Multidrug Resistance ABCB1 Transporter Mohammad Assad, Zahida Parveen, Saira Farman, Beenish Khurshid, Muhammad Ali Hashmi, Khalid Mohammed Khan, Akif Khurshid
91 [GO] 2022―Dez―12 Investigating Derivatives of Tanshinone IIA Sulfonate Sodium and Chloroxine for Their Inhibition Activities against the SARS-CoV-2 Papain-like Protease Xin Chen, Ke Chen, Zhaoyong Zhang, Peilan Wei, Lu Zhang, Yunxia Xu, et al. (+9)
92 [GO] 2022―Dez―08 Robustness of FTIR-Based Ultrarapid COVID-19 Diagnosis Using PLS-DA Sreejith Remanan Pushpa, Rajeev Kumar Sukumaran, Sivaraman Savithri
93 [GO] 2022―Dez―05 Identification of Human miRNA Biomarkers Targeting the SARS-CoV-2 Genome Indrajit Saha, Nimisha Ghosh, Dariusz Plewczynski
94 [GO] 2022―Dez―02 Critical Review of Plant-Derived Compounds as Possible Inhibitors of SARS-CoV-2 Proteases: A Comparison with Experimentally Validated Molecules Yasel Guerra, Diana Celi, Paul Cueva, Yunierkis Perez-Castillo, Francesca Giampieri, José Miguel Alvarez-Suarez, Eduardo Tejera
95 [GO] 2022―Nov―18 Unveiling the Biomarkers of Cancer and COVID-19 and Their Regulations in Different Organs by Integrating RNA-Seq Expression and Protein-Protein Interactions Nimisha Ghosh, Indrajit Saha, Dariusz Plewczynski
96 [GO] 2022―Nov―18 Green and Regioselective Approach for the Synthesis of 3-Substituted Indole Based 1,2-Dihydropyridine and Azaxanthone Derivatives as a Potential Lead for SARS-CoV-2 and Delta Plus Mutant Virus: DFT and Docking Studies Kamalraja Jayabal, Dhanasekar Elumalai, Saraswathi Leelakrishnan, Suman Bhattacharya, Venkatesan Rengarajan, Tharanikkarasu Kannan, Shih-Ching Chuang
97 [GO] 2022―Nov―13 Deuterated Drugs and Biomarkers in the COVID-19 Pandemic Ross D. Jansen-van Vuuren, Luka Jedlovčnik, Janez Košmrlj, Thomas E. Massey, Volker Derdau
98 [GO] 2022―Okt―21 Simultaneous Rapid Nucleic Acid and Protein Detection in a Lateral Chromatography Chip for COVID-19 Diagnosis Qiuyuan Lin, Jin Zhang, Liling Liu, Jilie Kong, Xueen Fang
99 [GO] 2022―Okt―11 microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model Elif Damla Arisan, D. Alwyn Dart, Guy H. Grant, Andrew Dalby, Derya Dilek Kancagi, Raife Dilek Turan, et al. (+5)
100 [GO] 2022―Okt―07 Dissection of the Active Ingredients and Potential Mechanism of Han-Shi-Yu-Fei-Decoction in Treating COVID-19 Based on In Vivo Substances Profiling and Clinical Symptom-Guided Network Pharmacology Guangyang Jiao, Xiangcheng Fan, Yejian Wang, Nan Weng, Luolan Ouyang, Haoqian Wang, et al. (+5)
101 [GO] 2022―Okt―06 Development and Evaluation of a Rapid Neutralizing Antibody Assay for COVID-19 Vaccination Heshan Yu, Huan Liu, Yongju Yang, Xuefeng Guan
102 [GO] 2022―Okt―06 Effect of Disulfide Bridge on the Binding of SARS-CoV-2 Fusion Peptide to Cell Membrane: A Coarse-Grained Study Hujun Shen, Zhenhua Wu
103 [GO] 2022―Okt―05 Nanozyme and Stimulated Fluorescent Cu-Based Metal-Organic Frameworks (Cu-MOFs) Functionalized with Engineered Aptamers as a Molecular Recognition Element for Thrombin Detection in the Plasma of COVID-19 Patients Gona K. Ali, Khalid M. Omer
104 [GO] 2022―Sep―30 Assessing the Vulnerability of Cancer Patients for COVID-19 Saloni Bhatia, Padmini Gokhale, Teesta Katte, Shreeshanthi Acharya, Avinash Arvind Rasalkar, Soumya Vidapanakal, et al. (+6)
105 [GO] 2022―Sep―16 Association of SARS-CoV-2 and Polypharmacy with Gut-Lung Axis: From Pathogenesis to Treatment Jonaid Ahmad Malik, Sakeel Ahmed, Zahid Yaseen, Muteb Alanazi, Tareq Nafea Alharby, Hisham Abdulaziz Alshammari, Sirajudheen Anwar
106 [GO] 2022―Sep―14 Visible Light-Promoted Green and Sustainable Approach for One-Pot Synthesis of 4,4’-(Arylmethylene)bis(1H-pyrazol-5-ols), In Vitro Anticancer Activity, and Molecular Docking with Covid-19 Mpro Anamika Gupta, Safia Iqbal, Mohd. Kamil Hussain, Mohd. Rehan Zaheer, Krapa Shankar
107 [GO] 2022―Aug―29 Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice Ana C. Puhl, Giovanni F. Gomes, Samara Damasceno, Ethan J. Fritch, James A. Levi, Nicole J. Johnson, et al. (+16)
108 [GO] 2022―Aug―25 Potential of ATR-FTIR-Chemometrics in Covid-19: Disease Recognition Octavio Calvo-Gomez, Hiram Calvo, Leticia Cedillo-Barrón, Héctor Vivanco-Cid, Juan Manuel Alvarado-Orozco, David Andrés Fernandez-Benavides, et al. (+5)
109 [GO] 2022―Aug―25 Molecular Dynamics Analysis of Fast-Spreading Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Their Effects on the Interaction with Human Angiotensin-Converting Enzyme 2 Anacleto Silva de Souza, Vitor Martins de Freitas Amorim, Gabriela D. A. Guardia, Felipe R. C. dos Santos, Filipe F. dos Santos, Robson Francisco de Souza, et al. (+9)
110 [GO] 2022―Aug―17 A Computational Study on the Interaction of NSP10 and NSP14: Unraveling the RNA Synthesis Proofreading Mechanism in SARS-CoV-2, SARS-CoV, and MERS-CoV Himakshi Sarma, G. Narahari Sastry
111 [GO] 2022―Aug―09 Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain Yoel Rodríguez, Scarlet Martínez Cardoze, Onyinyechi W. Obineche, Claudia Melo, Ashanna Persaud, José A. Fernández Romero
112 [GO] 2022―Aug―08 Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors Ana C. Puhl, Melina Mottin, Carolina Q. Sacramento, Tatyana Almeida Tavella, Gabriel Gonçalves Dias, Natalia Fintelman-Rodrigues, et al. (+10)
113 [GO] 2022―Aug―04 Multiwalled Carbon Nanotube-Based On-Body Patch Antenna for Detecting COVID-19-Affected Lungs Raja Rashidul Hasan, Ahmed Mortuza Saleque, Afrin Binte Anwar, Md. Abdur Rahman, Yuen Hong Tsang
114 [GO] 2022―Jul―28 Exploring the Potential of Chemical Inhibitors for Targeting Post-translational Glycosylation of Coronavirus (SARS-CoV-2) Nancy Tripathi, Bharat Goel, Nivedita Bhardwaj, Ram A. Vishwakarma, Shreyans K. Jain
115 [GO] 2022―Jul―21 Temperature-Responsive Liposome-Linked Immunosorbent Assay for the Rapid Detection of SARS-CoV-2 Using Immunoliposomes Runkai Hu, Morihiro Hotta, Taro Maruyama, Mizuki Fujisawa, Keitaro Sou, Shinji Takeoka
116 [GO] 2022―Jul―14 Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety Oi Wah Liew, Felic Fanusi, Jessica Yan Xia Ng, Bintou Ahmadou Ahidjo, Samantha Shi Min Ling, Shera Lilyanna, et al. (+7)
117 [GO] 2022―Jul―08 Tricyclic Aza-Andrographolide Derivatives from Late-Stage Hydroamination and Their Anti-human Coronavirus (Anti-HCoV) Activity Chao Che, Ding Jiang, Jiayin Zhang, Qi Xing, Ting Li, Yi Zhao, et al. (+5)
118 [GO] 2022―Jun―28 Online Predictor Using Machine Learning to Predict Novel Coronavirus and Other Pathogenic Viruses Jnanendra Prasad Sarkar, Indrajit Saha, Nimisha Ghosh, Debasree Maity, Dariusz Plewczynski
119 [GO] 2022―Jun―22 PMMA Microcapsules for the Inactivation of SARS-CoV-2 Vânia I. Sousa, Joana F. Parente, Juliana F. Marques, Carla Calçada, Maria I. Veiga, Nuno S. Osório, Carlos J. Tavares
120 [GO] 2022―Jun―16 Eryngium creticum L.: Chemical Characterization, SARS-CoV-2 Inhibitory Activity, and In Silico Study Marwa Elsbaey, Mahmoud A. A. Ibrahim, Ahmed M. Shawky, Tomofumi Miyamoto
121 [GO] 2022―Jun―13 Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease Amgad M. Rabie
122 [GO] 2022―Jun―07 Human miRNAs to Identify Potential Regions of SARS-CoV-2 Nimisha Ghosh, Indrajit Saha, Nikhil Sharma, Jnanendra Prasad Sarkar
123 [GO] 2022―Mai―24 Fluorine in Medicinal Chemistry: In Perspective to COVID-19 Cheng Zhang
124 [GO] 2022―Mai―23 Effect of Surface Porosity on SARS-CoV-2 Fomite Infectivity Mohsen Hosseini, Leo L. M. Poon, Alex W. H. Chin, William A. Ducker
125 [GO] 2022―Mai―10 Biophysical Insight into the SARS-CoV2 Spike-ACE2 Interaction and Its Modulation by Hepcidin through a Multifaceted Computational Approach Hamid Hadi-Alijanvand, Luisa Di Paola, Guang Hu, David M. Leitner, Gennady M. Verkhivker, Peixin Sun, et al. (+2)
126 [GO] 2022―Mai―09 Identification of Endogenous Peptides in Nasal Swab Transport Media used in MALDI-TOF-MS Based COVID-19 Screening Helen Tsai, Brett S. Phinney, Gabriela Grigorean, Michelle R. Salemi, Hooman H. Rashidi, John Pepper, Nam K. Tran
127 [GO] 2022―Apr―28 Neutralizing Effect of Synthetic Peptides toward SARS-CoV-2 Pedro F.N. Souza, Maurício F. vanTilburg, Felipe P. Mesquita, Jackson L. Amaral, Luina B. Lima, Raquel C. Montenegro, et al. (+10)
128 [GO] 2022―Apr―05 Emerging Electrochemical Biosensing Trends for Rapid Diagnosis of COVID-19 Biomarkers as Point-of-Care Platforms: A Critical Review Sasya Madhurantakam, Sriram Muthukumar, Shalini Prasad
129 [GO] 2022―Mrz―29 In Vitro Nasal Tissue Model for the Validation of Nasopharyngeal and Midturbinate Swabs for SARS-CoV-2 Testing Devon R. Hartigan, Miryam Adelfio, Molly E. Shutt, Stephanie M. Jones, Shreya Patel, Joshua T. Marchand, et al. (+3)
130 [GO] 2022―Mrz―07 Semen Proteomics of COVID-19 Convalescent Men Reveals Disruption of Key Biological Pathways Relevant to Male Reproductive Function Susmita Ghosh, Swapneil Parikh, Mehar Un Nissa, Arup Acharjee, Avinash Singh, Dhruv Patwa, et al. (+6)
131 [GO] 2022―Feb―23 Blocking SARS-CoV-2 Delta Variant (B.1.617.2) Spike Protein Receptor-Binding Domain Binding with the ACE2 Receptor of the Host Cell and Inhibiting Virus Infections Using Human Host Defense Peptide-Conjugated Graphene Quantum Dots Avijit Pramanik, Poonam C. Sharma, Shamily Patibandla, Ye Gao, Vinod Ruppa-Kasani, Jagruti Goli, et al. (+7)
132 [GO] 2022―Feb―15 Binding Studies of the Prodrug HAO472 to SARS-Cov-2 Nsp9 and Variants Miaomiao Liu, Dene R. Littler, Jamie Rossjohn, Ronald J Quinn
133 [GO] 2022―Feb―07 DirectDetect SARS-CoV-2 Direct Real-Time RT-PCR Study Using Patient Samples Dulguunnaran Naranbat, Lindsay Schneider, Rami Kantor, Curt G. Beckwith, Lauri Bazerman, Fizza Gillani, et al. (+9)
134 [GO] 2022―Feb―01 Laser-Induced Graphene (LIG) as a Smart and Sustainable Material to Restrain Pandemics and Endemics: A Perspective Nandini Dixit, Swatantra P. Singh
135 [GO] 2022―Jan―14 Preparation and Characterization of ACE2 Receptor Inhibitor-Loaded Chitosan Hydrogels for Nasal Formulation to Reduce the Risk of COVID-19 Viral Infection Barbara Vörös-Horváth, Pavo Živković, Krisztina Bánfai, Judit Bóvári-Biri, Judit Pongrácz, Gábor Bálint, et al. (+2)
136 [GO] 2022―Jan―11 Potent Inhibitory Activities of the Adenosine Analogue Cordycepin on SARS-CoV-2 Replication Amgad M. Rabie
137 [GO] 2022―Jan―07 Wet-Etched Microchamber Array Digital PCR Chip for SARS-CoV-2 Virus and Ultra-Early Stage Lung Cancer Quantitative Detection Yimeng Sun, Yaru Huang, Tong Qi, Qinghui Jin, Chunping Jia, Jianlong Zhao, et al. (+2)
138 [GO] 2021―Dez―29 Phage Display-Derived Peptide for the Specific Binding of SARS-CoV-2 Fan Yang, Li Liu, Pierre Fernand Neuenschwander, Steven Idell, Ramakrishna Vankayalapati, Krishan Gopal Jain, et al. (+3)
139 [GO] 2021―Dez―16 Aptamer Sandwich Assay for the Detection of SARS-CoV-2 Spike Protein Antigen Marketa Svobodova, Vasso Skouridou, Miriam Jauset-Rubio, Irene Viéitez, Alberto Fernández-Villar, Jorge Julio Cabrera Alvargonzalez, et al. (+6)
140 [GO] 2021―Dez―08 Identification of SARS-CoV-2 Proteins from Nasopharyngeal Swabs Probed by Multiple Reaction Monitoring Tandem Mass Spectrometry Gabriella Pinto, Anna Illiano, Veronica Ferrucci, Fabrizio Quarantelli, Carolina Fontanarosa, Roberto Siciliano, et al. (+6)
141 [GO] 2021―Nov―17 Combination of Carbon Nanofiber-Based Electrochemical Biosensor and Cotton Fiber: A Device for the Detection of the Middle-East Respiratory Syndrome Coronavirus Shimaa Eissa, Khaled Al-Kattan, Mohammed Zourob
142 [GO] 2021―Nov―10 Mutation-Induced Long-Range Allosteric Interactions in the Spike Protein Determine the Infectivity of SARS-CoV-2 Emerging Variants Jayanta Kumar Das, Bikash Thakuri, Krishnan MohanKumar, Swarup Roy, Adnan Sljoka, Gui-Quan Sun, Amit Chakraborty
143 [GO] 2021―Nov―08 Mass Spectrometry in Wastewater-Based Epidemiology for the Determination of Small and Large Molecules as Biomarkers of Exposure: Toward a Global View of Environment and Human Health under the COVID-19 Outbreak Yolanda Picó, Damià Barceló
144 [GO] 2021―Okt―29 Paper-Based Biosensors for COVID-19: A Review of Innovative Tools for Controlling the Pandemic Tomás Pinheiro, A. Rita Cardoso, Cristina E. A. Sousa, Ana C. Marques, Ana P. M. Tavares, Ana Miguel Matos, et al. (+5)
145 [GO] 2021―Okt―21 Recent Progress in Modified Polymer-Based PPE in Fight Against COVID-19 and Beyond Tanyaradzwa S. Muzata, Amanuel Gebrekrstos, Suprakas Sinha Ray
146 [GO] 2021―Okt―19 Remote Learning of COVID-19 Kinetic Analysis in a Physical Chemistry Laboratory Class Kelle D. Hart, Chelsea Thompson, Clay Burger, Dylan Hardwick, Amanda H. Michaud, Abdul H.M. Al Bulushi, et al. (+3)
147 [GO] 2021―Sep―30 Sensitive Determination of SARS-COV-2 and the Anti-hepatitis C Virus Agent Velpatasvir Enabled by Novel Metal-Organic Frameworks Mahmoud A. Saleh, Mona A. Mohamed, Ahmed Shahat, Nageh K. Allam
148 [GO] 2021―Sep―28 Multiplex Biosensing for Simultaneous Detection of Mutations in SARS-CoV-2 Hui Xi, Hanlin Jiang, Mario Juhas, Yang Zhang
149 [GO] 2021―Sep―27 Atomistic Simulations and In Silico Mutational Profiling of Protein Stability and Binding in the SARS-CoV-2 Spike Protein Complexes with Nanobodies: Molecular Determinants of Mutational Escape Mechanisms Gennady M. Verkhivker, Steve Agajanian, Deniz Yasar Oztas, Grace Gupta
150 [GO] 2021―Sep―21 Antibody Screening Results for Anti-Nucleocapsid Antibodies Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2 Nucleocapsid Protein David M. Cate, Joshua D. Bishop, Helen V. Hsieh, Veronika A. Glukhova, Luis F. Alonzo, H. Gleda Hermansky, et al. (+14)
151 [GO] 2021―Sep―02 Antiviral Face Mask Functionalized with Solidified Hand Soap: Low-Cost Infection Prevention Clothing against Enveloped Viruses Such as SARS-CoV-2 Alba Cano-Vicent, Alberto Tuñón-Molina, Miguel Martí, Yukiko Muramoto, Takeshi Noda, Kazuo Takayama, Ángel Serrano-Aroca
152 [GO] 2021―Sep―02 Activation Pathways and Free Energy Landscapes of the SARS-CoV-2 Spike Protein Yichao Wu, Ruixin Qian, Yan Yang, Yuebiao Sheng, Wenfei Li, Wei Wang
153 [GO] 2021―Jul―28 Simple Classification of RNA Sequences of Respiratory-Related Coronaviruses Louis Oberer, Angel Diaz Carral, Maria Fyta
154 [GO] 2021―Jul―27 Screening Antibodies Raised against the Spike Glycoprotein of SARS-CoV-2 to Support the Development of Rapid Antigen Assays Jason L. Cantera, David M. Cate, Allison Golden, Roger B. Peck, Lorraine L. Lillis, Gonzalo J. Domingo, et al. (+19)
155 [GO] 2021―Jul―20 Production of Proteins of the SARS-CoV-2 Proteome for Drug Discovery Choon Kim, Kiran V. Mahasenan, Atul Bhardwaj, Olaf Wiest, Mayland Chang, Shahriar Mobashery
156 [GO] 2021―Jul―16 Conformational Variability Correlation Prediction of Transmissibility and Neutralization Escape Ability for Multiple Mutation SARS-CoV-2 Strains using SSSCPreds Hiroshi Izumi, Laurence A. Nafie, Rina K. Dukor
157 [GO] 2021―Jun―24 SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics Benhong Xu, Yuxuan Lei, Xiaohu Ren, Feng Yin, Weihua Wu, Ying Sun, et al. (+8)
158 [GO] 2021―Jun―24 Anti-Covid-19 Drug Analogues: Synthesis of Novel Pyrimidine Thioglycosides as Antiviral Agents Against SARS-COV-2 and Avian Influenza H5N1 Viruses Mamdouh A. Abu-Zaied, Galal H. Elgemeie, Nashwa M. Mahmoud
159 [GO] 2021―Jun―23 CFD Simulation of the Airborne Transmission of COVID-19 Vectors Emitted during Respiratory Mechanisms: Revisiting the Concept of Safe Distance Ashish Magar, Manish Joshi, Pachalla S. Rajagopal, Arshad Khan, Madhukar M. Rao, Balvinder K. Sapra
160 [GO] 2021―Jun―17 Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib Eric J Niesor, Guy Boivin, Eric Rhéaume, Rong Shi, Véronique Lavoie, Nathalie Goyette, et al. (+4)
161 [GO] 2021―Jun―11 Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein Yan Wang, Zhen Wu, Wenhua Hu, Piliang Hao, Shuang Yang
162 [GO] 2021―Jun―09 Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant Gennady M. Verkhivker, Steve Agajanian, Deniz Yasar Oztas, Grace Gupta
163 [GO] 2021―Mai―04 Artificial Intelligence-Guided De Novo Molecular Design Targeting COVID-19 Srilok Srinivasan, Rohit Batra, Henry Chan, Ganesh Kamath, Mathew J. Cherukara, Subramanian K. R. S. Sankaranarayanan
164 [GO] 2021―Apr―01 Development of a Nucleocapsid Protein-Based ELISA for Detection of Human IgM and IgG Antibodies to SARS-CoV-2 Pan-pan Liu, Yang Zong, Shu-peng Jiang, Yong-jun Jiao, Xue-jie Yu
165 [GO] 2021―Mrz―23 Rapid Detection of SARS-CoV-2 Virus Using Dual Reverse Transcriptional Colorimetric Loop-Mediated Isothermal Amplification Chao Ji, Shuxia Xue, Min Yu, Jinyu Liu, Qin Zhang, Feng Zuo, et al. (+7)
166 [GO] 2021―Mrz―15 Quick and Easy Assembly of a One-Step qRT-PCR Kit for COVID-19 Diagnostics Using In-House Enzymes Masateru Takahashi, Muhammad Tehseen, Rahul Salunke, Etsuko Takahashi, Sara Mfarrej, Mohamed A. Sobhy, et al. (+16)
167 [GO] 2021―Mrz―10 Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms Ana C. Puhl, Ethan J. Fritch, Thomas R. Lane, Longping V. Tse, Boyd L. Yount, Carolina Q. Sacramento, et al. (+19)
168 [GO] 2021―Mrz―09 Proteomics Analysis of Serum from COVID-19 Patients Xiaoling Liu, Yinghao Cao, Hongmei Fu, Jie Wei, Jianhong Chen, Jun Hu, Bende Liu
169 [GO] 2021―Mrz―09 Ethyl Pyruvate as a Potential Defense Intervention against Cytokine Storm in COVID-19? Omprakash Tanwar, Aastha Soni, Pawan Prajapat, Tanu Shivhare, Pooja Pandey, Puneet Kumar Samaiya, et al. (+2)
170 [GO] 2021―Mrz―06 Preanalytical Issues and Cycle Threshold Values in SARS-CoV-2 Real-Time RT-PCR Testing: Should Test Results Include These? Ilka Engelmann, Enagnon Kazali Alidjinou, Judith Ogiez, Quentin Pagneux, Sana Miloudi, Ilyes Benhalima, et al. (+8)
171 [GO] 2021―Mrz―05 Fomite Transmission, Physicochemical Origin of Virus-Surface Interactions, and Disinfection Strategies for Enveloped Viruses with Applications to SARS-CoV-2 Nicolas Castaño, Seth C. Cordts, Myra Kurosu Jalil, Kevin S. Zhang, Saisneha Koppaka, Alison D. Bick, et al. (+2)
172 [GO] 2021―Mrz―05 Neutrophil Elastase and Proteinase 3 Cleavage Sites Are Adjacent to the Polybasic Sequence within the Proteolytic Sensitive Activation Loop of the SARS-CoV-2 Spike Protein Zhadyra Mustafa, Anuar Zhanapiya, Hubert Kalbacher, Timo Burster
173 [GO] 2021―Mrz―04 Investigating the Internalization and COVID-19 Antiviral Computational Analysis of Optimized Nanoscale Zinc Oxide Mohamed Hamdi, Hend Mohamed Abdel-Bar, Enas Elmowafy, Ahmed El-khouly, Mai Mansour, Gehanne A.S. Awad
174 [GO] 2021―Mrz―03 SARS-CoV-2 Genome from the Khyber Pakhtunkhwa Province of Pakistan Muhammad Tahir Khan, Sajid Ali, Anwar Sheed Khan, Noor Muhammad, Faiza Khalil, Muhammad Ishfaq, et al. (+6)
175 [GO] 2021―Mrz―03 SARS-CoV-2: The Road Less Traveled-From the Respiratory Mucosa to the Brain Jayamuruga Pandian Arunachalam, Anoop U.R., Kavita Verma, Rahini Rajendran, Subbulakshmi Chidambaram
176 [GO] 2021―Mrz―02 MXene-Graphene Field-Effect Transistor Sensing of Influenza Virus and SARS-CoV-2 Yanxiao Li, Zhekun Peng, Natalie J. Holl, Md. Rifat Hassan, John M. Pappas, Congjie Wei, et al. (+7)
177 [GO] 2021―Feb―06 Novel Development of Predictive Feature Fingerprints to Identify Chemistry-Based Features for the Effective Drug Design of SARS-CoV-2 Target Antagonists and Inhibitors Using Machine Learning Kelvin Cooper, Christopher Baddeley, Bernie French, Katherine Gibson, James Golden, Thiam Lee, et al. (+3)
178 [GO] 2021―Jan―27 Specific and Rapid SARS-CoV-2 Identification Based on LC-MS/MS Analysis Ofir Schuster, Anat Zvi, Osnat Rosen, Hagit Achdout, Amir Ben-Shmuel, Ohad Shifman, et al. (+3)
179 [GO] 2021―Jan―21 SARSCOVIDB-A New Platform for the Analysis of the Molecular Impact of SARS-CoV-2 Viral Infection Rafael Lopes da Rosa, Tung Sheng Yang, Emanuela Fernanda Tureta, Laura Rascovetzki Saciloto de Oliveira, Amanda Naiara Silva Moraes, Juliana Miranda Tatara, et al. (+7)
180 [GO] 2021―Jan―20 Machine Learning-Driven and Smartphone-Based Fluorescence Detection for CRISPR Diagnostic of SARS-CoV-2 Aubin Samacoits, Pattaraporn Nimsamer, Oraphan Mayuramart, Naphat Chantaravisoot, Pitchaya Sitthi-amorn, Chajchawan Nakhakes, et al. (+10)
181 [GO] 2020―Dez―22 Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis Natalia G. Herrera, Nicholas C. Morano, Alev Celikgil, George I. Georgiev, Ryan J. Malonis, James H. Lee, et al. (+28)
182 [GO] 2020―Dez―18 Structure-Based Virtual Screening and Biochemical Validation to Discover a Potential Inhibitor of the SARS-CoV-2 Main Protease Akshita Gupta, Chitra Rani, Pradeep Pant, Viswanathan Vijayan, Naval Vikram, Punit Kaur, et al. (+3)
183 [GO] 2020―Nov―19 Similarity and Specificity of Traditional Chinese Medicine Formulas for Management of Coronavirus Disease 2019 and Rheumatoid Arthritis Zheng Li, Hongwei Chen, Huixia Zhang, Yan Li, Caiyun Wang, Liping Bai, et al. (+2)
184 [GO] 2020―Nov―19 SSSCPreds: Deep Neural Network-Based Software for the Prediction of Conformational Variability and Application to SARS-CoV-2 Hiroshi Izumi, Laurence A. Nafie, Rina K. Dukor
185 [GO] 2020―Nov―12 Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19 Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel
186 [GO] 2020―Okt―14 Quantitative Structure-Activity Relationship Machine Learning Models and their Applications for Identifying Viral 3CLpro- and RdRp-Targeting Compounds as Potential Therapeutics for COVID-19 and Related Viral Infections Julian Ivanov, Dmitrii Polshakov, Junko Kato-Weinstein, Qiongqiong Zhou, Yingzhu Li, Roger Granet, et al. (+6)
187 [GO] 2020―Jul―14 Prediction of Small Molecule Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus-2 RNA-dependent RNA Polymerase Mohammed Ahmad, Abhisek Dwivedy, Richard Mariadasse, Satish Tiwari, Deepsikha Kar, Jeyaraman Jeyakanthan, Bichitra K. Biswal
188 [GO] 2020―Jun―23 Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor Sanchita Hati, Sudeep Bhattacharyya
189 [GO] 2020―Jun―23 Correction to Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil Bui Thi Phuong Thuy, Tran Thi Ai My, Nguyen Thi Thanh Hai, Le Trung Hieu, Tran Thai Hoa, Huynh Thi Phuong Loan, et al. (+10)
190 [GO] 2020―Mai―18 Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow Assay Chao Huang, Tian Wen, Feng-Juan Shi, Xiao-Yan Zeng, Yong-Jun Jiao
191 [GO] 2020―Mrz―31 Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil Bui Thi Phuong Thuy, Tran Thi Ai My, Nguyen Thi Thanh Hai, Le Trung Hieu, Tran Thai Hoa, Huynh Thi Phuong Loan, et al. (+10)
 [1] 

191 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.008 sec